Early Features of Chronic Obstructive Pulmonary Disease in Patients with Asthma

To T. Stanojevic S. Moores G. et al.

Global asthma prevalence in adults: findings from the cross-sectional world health survey.

BMC public health. 12: 204Adeloye D. Chua S. Lee C. et al.

Global and regional estimates of COPD prevalence: systematic review and meta-analysis.

J Glob Health. 5: 020415

Global strategy for asthma management and prevention.

() ()

Global strategy for the diagnosis, management, and prevention of COPD.

() ()

Complex phenotypes in asthma: current definitions.

Pulm Pharmacol Ther. 26: 710-715Agache I. Akdis C. Jutel M. et al.

Untangling asthma phenotypes and endotypes.

Allergy. 67: 835-846Postma D.S. van den Berge M.

The different faces of the asthma-COPD overlap syndrome.

Eur Respir J. 46: 587-590

The many faces of asthma-chronic obstructive pulmonary disease overlap. Review.

Curr Opin Pulm Med. 25: 1-10

The overlap syndrome of asthma and COPD: what are its features and how important is it?.

Thorax. 64: 728-735Konstantellou E. Papaioannou A.I. Loukides S. et al.

Persistent airflow obstruction in patients with asthma: Characteristics of a distinct clinical phenotype.

Respir Med. 109: 1404-1409Orie N. Sluiter H.J. De Vries K. et al.

The host factor in bronchitis.

in: Orie N. Sluiter H.J. Bronchitis. Royal Van Gorcum, Assen: 43-49

Standards for the diagnosis and care of patients with chronic obstructive pulmonary diseases.

Am J Respir Crit Care Med. 152: S77-S121

Asthma-COPD Overlap syndrome: pathogenesis, clinical features, and therapeutic targets.

BMJ. 358: j3772

The Asthma-COPD Overlap Syndrome.

N Engl J Med. 373: 1241-1249Reddel H.K. Bacharier L.B. Bateman E.D. et al.

Global initiative for asthma (GINA) strategy 2021 - executive summary and rationale for key changes.

Am J Respir Crit Care Med. https://doi.org/10.1164/rccm.202109-2205PPBoulet L.P. Turcotte H. Hudon C. et al.

Clinical, physiological, and radiological features of asthma with incomplete reversibility of airflow obstruction compared with those of COPD.

Can Respir J. 5: 270-277Fabbri L.M. Romagnoli M. Corbetta L. et al.

Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease.

Am J Respir Crit Care Med. 167: 418-424Boulet L.P. Lemiere C. Archambault F. et al.

Smoking and asthma: clinical and radiologic features, lung function, and airway inflammation.

Chest. 129: 661-668

Persistent airway obstruction in asthma.

Am J Respir Crit Care Med. 187: 1-2

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease.

() ()

Chronic obstructive pulmonary disease.

Lancet. 389: 1931-1940Calverley P.M. Burge P.S. Spencer S. et al.

Bronchodilator reversibility testing in chronic obstructive pulmonary disease.

Thorax. 58: 659-664Tashkin D.P. Celli B. Decramer M. et al.

Bronchodilator responsiveness in patients with COPD.

Eur Resp J. 31: 742-750Tashkin D.P. Altose M.D. Bleecker E.R. et al.

The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation.

Am Rev Respir Dis. 145: 301-310van den Berge M. Vonk J.M. Gosman M. et al.

Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD.

Eur Resp J. 40: 1098-1105

Eosinophilic airway inflammation in COPD.

Int J COPD. 1: 39-47Saetta M. Di Stefano A. Maestrelli P. et al.

Eosinophilia in chronic bronchitis during exacerbations.

Am J Respir Crit Care Med. 150: 1646-1652Kitaguchi Y. Komatsu Y. Fujimoto K. et al.

Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma.

Int J COPD. 7: 283-289Han M.K. Agusti A. Celli B.R. et al.

From GOLD 0 to Pre-COPD.

Am J Respir Crit Care Med. 203: 414-423

Asthma with a smoking history and pre–chronic obstructive pulmonary disease.

Am J Respir Crit Care Med. 204: 109-110

Characteristics of Asthma-COPD Overlap according to Various Criteria.

Tuberc Respir Dis (Seoul). 84: 87-88

Diagnosis of asthma-COPD overlap: the five commandments.

Eur Respir J. 49: 1700506Sin D.D. Miravitlles M. Mannino D.M. et al.

What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion.

Eur Respir J. 48: 664-673Plaza V. Álvarez F. Calle M. et al.

Consensus on the Asthma-COPD Overlap Syndrome (ACOS) Between the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA).

Arch Bronconeumol. 53: 443-449Soler-Cataluña J.J. Cosío B. Izquierdo J.L. et al.

Consensus document on the overlap phenotype COPD-asthmna in COPD.

Arch Bronconeumol. 48: 331-337Mekov E. Nuñez A. Sin D.D. et al.

Update on Asthma-COPD Overlap (ACO): a narrative review.

Int J Chron Obstruct Pulmon Dis. 16: 1783-1799Gibson P.G. McDonald V.M.

Asthma-COPD overlap 2015: now we are six.

Thorax. 70: 683-691

Asthma and smoking-induced airway disease without spirometric COPD.

Eur Respir J. 49Price D. Crockett A. Arne M. et al.

Spirometry in primary care case-identification, diagnosis and management of COPD.

Prim Care Respir J. 18: 216-223Boulet L.P. Boulay M.È. Dérival J.L. et al.

Asthma-COPD Overlap Phenotypes and Smoking: Comparative features of asthma in smoking or non-smoking patients with an incomplete reversibility of airway obstruction.

COPD. 15: 130-138St-Laurent J. Bergeron C. Page N. et al.

Influence of smoking on airway inflammation and remodelling in asthma.

Clin Exp Allergy. 38: 1582-1589Lange P. Celli B. Agustí A. et al.

Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease.

N Engl J Med. 373: 111-122Agusti A. Bel E. Thomas M. et al.

Treatable traits: toward precision medicine of chronic airway diseases.

Eur Respir J. 47: 410-419Pavord I.D. Beasley R. Agusti A. et al.

After asthma: redefining airways diseases.

Lancet. 391: 350-400

Asthma-COPD Overlap (ACO) PRO-CON Debate. ACO: Call Me by My Name.

COPD. 17: 471-473

Cigarette smoking and asthma: a dangerous mix.

Can Respir J. 12: 79-80Thomson N.C. Chaudhuri R.

Asthma in smokers: challenges and opportunities.

Curr Opin Pulm Med. 15: 39-45Thomson N.C. Chaudhuri R. Heaney L.G. et al.

Clinical outcomes, and inflammatory biomarkers in current smokers and exsmokers with severe asthma.

J Allergy Clin Immunol. 131: 1008-1016

Risk factors associated with irreversible airflow limitation in asthma.

Curr Opin Allergy Clin Immunol. 8: 63-69

Irreversible airway obstruction in asthma.

Curr Allergy Asthma Rep. 9: 168-173Boulet L.P. Boulay M.E. Coxson H. et al.

Asthma with irreversible airway obstruction in smokers and non-smokers: links between airway inflammation and structural changes.

Respiration. 99: 1090-1100Morissette M. Godbout K. Côté A. et al.

Asthma COPD overlap: Insights into cellular and molecular mechanisms.

Mol Aspects Med. 85: 101021

Long-term outcomes of congenital lung malformations.

Semin Pediatr Surg. 26: 311-316Sprio A.E. Ciprandi G. Riccardi E. et al.

The influence of smoking on asthma in the real-life.

Respir Med. 170: 106066Perret J.L. Dharmage S.C. Matheson M.C. et al.

The interplay between the effects of lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age.

Am J Respir Crit Care Med. 187: 42-48Assad N.A. Balmes J. Mehta S. et al.

Chronic obstructive pulmonary disease secondary to household air pollution.

Sem Resp Crit Care Med. 36: 408-421To T. Zhu J. Larsen K. et al.

Progression from asthma to chronic obstructive pulmonary disease. is air pollution a risk factor?.

Am J Respir Crit Care Med. 194: 429-438Tan W.C. Sin D.D. Bourbeau J. et al.

Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study.

Thorax. 70: 822-829Tomlinson J.E.M. McMahon A.D. Chaudhuri R. et al.

Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma.

Thorax. 60: 282-287

Challenges in the management of asthma associated with smoking-induced airway diseases.

Expert Opin Pharmacother. 19: 1565-1579Pedersen S.E. Bateman E.D. Bousquet J. et al.

Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma control study.

J Allergy Clin Immunol. 120: 1036-1042

Therapeutic approaches of asthma and COPD overlap.

Allergol Int. 67: 187-190Bacharier L.B. Mori A. Kita H.

Advances in asthma, asthma-COPD overlap, and related biologics in 2018.

J Allergy Clin Immunol. 144: 906-919

留言 (0)

沒有登入
gif